Mar 03, 2021 / 08:20PM GMT
Doug Schenkel - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
All right. Hi, everybody. This is Doug Schenkel from the Cowen Life Science and Diagnostic Tools team. It's my pleasure to welcome Dr. John Dobak, President and Chief Executive Officer; as well as Kevin Sun, Chief Financial Officer, from DermTech.
DermTech is a company that has designed, developed and commercialized a noninvasive approach for the diagnosis of melanoma. This is accomplished through their main product called PLA, which is an acronym for Pigmented Lesion Assay. And this uses a smart sticker technology to collect a sample non-invasively from a pigmented lesion.
I'm going to hand it over to John and Kevin momentarily. And they'll spend a few minutes just providing a refresher or an introduction to the story for those who are new to DermTech. And then with the time left, we'll try to talk a little bit about the outlook for 2021, ask some follow-ups on existing and pipeline initiatives -- existing products and product pipeline initiatives. And then if we happen to have any time, we may
DermTech Inc at Cowen Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers